Emergency Medicine Cardiac Research and Education Group
CRUSADE Quality Improvement Initiative
Launched in 2001, CRUSADE is a national quality improvement initiative, designed to increase the practice of evidence-based medicine for patients diagnosed with non-ST segment elevation acute coronary syndromes (NSTE ACS) (i.e., unstable angina or NSTE myocardial infarction).
Through a continuous cycle of data collection, performance feedback and quality improvement interventions, over 500 participating sites in the US are consistently improving the standard of care for patients with NSTE ACS. Because of the dedication of the participating hospitals to this mission, over 200,000 cases have been submitted to the CRUSADE database. For more information visit the CRUSADE website.
In 2007, a milestone occurred. Duke Clinical Research Institute and its CRUSADE leadership joined forces with the American College of Cardiology Foundation's National Cardiovascular Data Registry (NCDR™) to launch a new initiative to improve the safety and outcomes for patients with ACS through the development of NCDR-ACTION™. This initiative will combine the data collection and quality reporting features of two leading national ACS registries to create the largest and most comprehensive national cardiovascular patient database ever developed. For more information visit the NCDR-ACTION Registry™ visit the website or call 800-257-4737 for more information.
Join EMCREG at SAEM 2008 in Washington, DC!
Join EMCREG for our 7th Annual SAEM Satellite event!
Specific date to be announced soon!
Join EMCREG as we hold our 7th ANNUAL satellite symposium at SAEM covering state-of-the-art topics in cardiovascular, neurovascular and other hot-topic emergencies. This SAEM-approved event will be held during the 2008 annual meeting in Washington, DC. For more information about the SAEM meeting, see the SAEM Meeting site. To pre-register, please contact support@emcreg.org.
.
Visit SAEM's event site for more information on this years Annual Meeting.
ACEP 2007 EMCREG Symposia: Cardiovascular, Neurovascular and Infectious Emergencies
Miss us at ACEP 2007?
View all the Presentations On-line! Please feel to view the webcasts of each presentation. These webcasts are free of charge and includes CME for those who register before viewing.
These symposia represented a unique opportunity to hear and interact with experts in emergency cardiovascular, neurovascular and infectious care and to gain up-to-date knowledge on the full spectrum of decision-making and care for patients with stroke and TIA, acute heart failure, hypertensive emergencies, acute coronary syndromes (ACS) including non-ST-segment elevation MI (NSTEMI) and ST-segment elevation myocardial infarction (STEMI), severe bacterial infections, and venous thromboembolism (DVT and PE).
It is our hope that this material will provide emergency physicians with information necessary to improve and facilitate care for this unique patient
population.
ACEP 2006 EMCREG Symposia: Cardiovascular and Neurovascular Emergencies and Point-of-Care Discussion Panel
View all the Presentations On-line! Please feel to view the webcasts of each presentation. These webcasts are free of charge and includes CME for those who register before viewing.
These symposia represented a unique opportunity to hear and interact with experts in emergency cardiovascular care and to gain up-to-date knowledge on the full spectrum of decision-making and care for patients with acute coronary syndromes (ACS). Topics include anti-platelet management in NSTE ACS, anti-thrombin therapy in ACS, STEMI fibrinolytics, time to treatment in STEMI, hypertension in stroke, lactate in trauma and resuscitation, and acute decompensated heart failure (ADHF). We also had a fantastic multidisciplinary expert discussion panel on the implementation of point-of-care testing in the ED, including perspectives from cardiology, the ED, the laboratory and administration.
It is our hope that this material will provide emergency physicians with information necessary to improve and facilitate care for this unique patient
population.
ACEP 2005 EMCREG Symposia: Cardiovascular and Neurovascular Emergencies and Point-of-Care Discussion Panel
These symposia represented a unique opportunity to hear and interact with experts in emergency cardiovascular care and to gain up-to-date knowledge on the full spectrum of decision-making and care for patients with acute coronary syndromes (ACS), acute decompensated heart failure (ADHF), and pulmonary embolism (PE), National Cholesterol Education Program Guidelines, Clopidogrel in ACS, LMWH in ACS, Stroke, Stroke Centers and TIA. We also had a first ever multidisciplinary expert discussion panel on the implementation of point-of-care testing in the ED.
It is our hope that
this material will provide emergency physicians with information necessary to improve and facilitate care for this unique patient
population.
The Emergency Diagnosis and Treatment of Acute Decompensated Heart Failure
Each year, nearly one million patients in the United States are hospitalized with acute decompensated heart failure (ADHF). In the
past, there have been limited practice guidelines for the emergency management of this condition. Data from the ADHERE (the
Acute Decompensated Heart Failure National Registry), indicate that ADHF patients are repeatedly hospitalized, and otherwise have
a very high rate of morbidity and mortality. The management and care of this patient group remains suboptimal. This comprehensive
and progressive monograph will review the latest diagnostic and therapeutic modalities for ADHF and suggest methods to improve
the care for these patients at your institution. Insights and lessons from ADHERE will also be reviewed and discussed.
The Emergency Medicine Cardiac Research and Education Group-International (EMCREG) is pleased to present this educational
monograph summarizing our 2005 EMCREG Symposium on the Emergency Department Diagnosis and Treatment of ADHF held in
Orlando, Florida. Join Drs. Judd E. Hollander, W. Frank Peaccock, William T. Abraham, Douglas
Char, and Sean P. Collins as they discusses the emergency diagnosis and
treatment of ADHF patients. It is our hope that
this material will provide emergency physicians with information necessary to improve and facilitate care for this unique patient
population.
Patients presenting to the Emergency Department (ED) with cardiovascular and neurovascular
emergencies remain a major clinical challenge. In the United States alone, there are over ten
million annual visits for these conditions, resulting in over three million hospital admissions.
Nontraumatic chest discomfort remains the primary catalyst for ED evaluation of possible acute
coronary syndromes (ACS), including unstable angina, non-Q wave myocardial infarction and
ST-segment elevation myocardial infarction. The diagnosis and treatment of congestive heart
failure (CHF) are also important to emergency physicians and other healthcare providers. The
diagnosis and treatment of cerebrovascular disease is equally difficult, with up to one million
patients presenting to the emergency department with stroke each year. Therefore, it is
essential that emergency physicians remain on the forefront of state of the art diagnostic and
treatment options involving the newest regimens for ACS, CHF, and neurovascular emergencies.
The Emergency Medicine Cardiac Research and Education Group (EMCREG)-International is
pleased to present this educational monograph summarizing our 2004 EMCREG Symposium
on cardiovascular and neurovascular emergency care held in San Francisco. It is our hope
that this material will provide emergency physicians with information necessary to help care for
these seriously ill patients.
EMCREG™ - International Department of Emergency Medicine University of Cincinnati College of Medicine
ML 0769, Room 6107
231 Albert Sabin Way
Cincinnati, Ohio 45267-0769
Fell free to contact us toll-free at 1-866-4EMCREG (436-2734)
A recent NEJM article reports that cardiac troponin elevation is associated with increased in-hospital mortality in patients with acute decompensated heart failure
A study reports that STEMI patients with combined factors such as older age, female gender, Hispanic or Black race, and diabetes have much longer delays in STEMI presentation.
Researchers report that the additional patients diagnosed with MI rather than UA since the definition of MI was redefined have an even higher long-term mortality.
Experts suggest that discrepancies in recommendations for optimal anticoagulation treatment in updated US and European ACS management guidelines are confusing for clinicians.
Researchers report that "midregional" pro-atrial natriuretic peptide is a strong predictor of adverse outcome after AMI, and gives complementary information when combined with measurement of the prohormone of BNP.
A study reports effective triage using a portable ultrasound device that can accurately screen emergency department patients with dyspnea for venous thromboembolism.
Researchers in Israel propose that patients with transient ST-elevation myocardial infarction (TSTEMI) may benefit from immediate, intense medical therapy and an early invasive approach.
The ACUITY data suggests ACS patients with diabetes are likely to have more ischemia and bleeding than other patients, but these adverse events can be minimized by bilvalirudin monotherapy
